Image - Barts and The London logo and link to home page Image - divider Image - divider
 
  Image - Wolfson Institute of Preventive Medicine title and link to Institute home page
Images - preventive medicine, people
  Image - Centre for Environmental and Preventive Medicine title and link to Centre homepage
 
Centre for Environmental and Preventive Medicine: publications 1992
Alberman E. After Windscale (Sellafield) (leader). British Medical Journal 1992;304: 1393-4.
Alberman E. Spontaneous abortions: epidemiology. In: Spontaneous abortion. Ed: Stabile I, Grudzinskas G, Chard T. London:SpringerVerlag, 1992, pp 9-20.
Alberman E, Emanuel I, Filakti H, Evans S. The contrasting effects of parental birthweight and gestational age on the birthweight of offspring. Paediatric Perinatal Epidemiology 1992;6: 134-44.
Campbell J, Cass P, Wathen N, Stone R, Wald N. First trimester amniotic fluid and extraembryonic coelomic fluid acetylcholinesterase electrophoresis. Prenatal Diagnosis 1992;12:609-12.
Craig WY, Poulin SE, Forster NR, Neveux LM, Wald NJ, Ledue TB. Effect of sample storage on the assay of lipoprotein (a) by commercially available radial immunodiffusion and enzyme-linked immunosorbent assay kits. Clinical Chemistry 1992;38(4):550-2.
Cuckle HS, Densem JW, Wald NJ. Detection of hydatidiform mole in maternal serum screening programmes for Down's syndrome. British Journal of Obstetrics and Gynaecology 1992;99(6):495-7.
Cuckle HS, Wald NJ. Biochemical screening for Down's syndrome. In: Early Fetal Diagnosis:Recent Progress and Public Health Implications. Macek M, Ferguson Smith MA, Spala M (Eds). Karolinum, Charles University Press, Prague:330-335, 1992.
Cuckle HS, Wald NJ. hCG, estriol, and other maternal blood markers of fetal aneuploidy. In: Maternal serum screening for fetal genetic disorders Ed: Elias S and Simpson JL. Churchill-Livingstone, Edinburgh, 1992.
Cuckle HS, Wald NJ. The complementary use of biochemical serum tests and ultrasound in the detection of neural tube defects and Down syndrome: Part II Diagnosis. In: Textbook of Ultrasound in Obstetrics and Gynaecology. Ed: Chervenak FA, Isaacson G, Campbell S. Boston: Little Brown & Co,
Cuckle HS, Wald NJ, Densem JW, Canick JA, Abell KB. Second trimester amniotic fluid oestriol, dehydroepiandrosterone sulphate, and human chorionic gonadotropin levels in Down's syndrome pregnancies. British Journal of Obstetrics and Gynaecology 1991 ;98(11): 1160-2. 1992.
Emanuel I, Filakti H, Alberman E, Evans SJW, Williams S. Intergenerational studies of human birth weight from the 1958 Birth Cohort. 1. Evidence for a multi-generation effect. British Journal of Obstetrics and Gynaecology 1992;99:67-74.
Emanuel I, Filakti H, Alberman E, Evans SJW. Intergenerational studies of human birthweight from the 1958 birth cohort. II. Do parents who were twins have babies as heavy as those born to singletons? Br J Obstet Gynaecol 1992;99:836-40.
Jobst KA, Smith AD, Szatmari M, Molyneux A, Esiri ME, King E, Smith A, Jaskowski A, McDonald B, Wald N. Detection in life confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet 1992;340: 1179-83.
Kennard A. An update for GPs on using the triple test in pregnancy. Pulse 1992;52(20):64-6.
Law MR. Serum cholesterol and cancer. British Journal of Cancer 1992;65:307-8.
Law MR, Wald NJ, Meade TW. Screening for osteoporosis. (A reply to Stevenson et al). Lancet 1992;339:680.
Longnecker MP, Martin-Moreno JM, Knekt P, Nomura AMY, Schober SE, Stahalin HB, Wald NJ, Gey KF, Willett we. Serum alphatocopherol in relation to subsequent colorectal cancer: pooled data from five cohorts. Journal of National Cancer Institute 1992;84:430-5.
Mutch L, Alberman E, Hagberg B, Kodama K, Perat MY. Cerebral palsy epidemiology: where are we now and where are we going? Developmental Medicine and Child Neurology 1992;34:547-57.
Nicholson A, Alberman E. Cerebral palsy - an increasing contributor to severe mental retardation? Archives of Disease in Childhood 1992;67(8): 1050-5.
Parkes C and Wald N. "Perspectives - Views from the Experts" (An interview on Prostate Cancer Screening). PROspectives Newsletter. Contemporary issues in managing prostatic disease. Ed R Kirby, Oxford Clinical Communications. Page 8, 1992.
Poswillo D, Alberman E. Effects of smoking on the fetus, neonate and child. Oxford: Oxford University Press, 1992.
Wald N. A reply on passive smoking. Occupational Health Review 1992;34:35.
Wald NJ. Cholesterol and coronary heart disease: to screen or not to screen. In: Coronary Heart Disease Epidemiology. Marmot M, Elliott P, editors. Oxford: Oxford University Press, 1992.
Wald N. Are there any methods available to measure the amount of cigarette smoke in the atmosphere of a room? (letter). British Medical Journal 1992; 305:946.
Wald N and Cuckle H. Antenatal screening and diagnosis. In: The Epidemiology and Control of Neural Tube Defects Eds: Elwood JM, Little J, and Elwood JH. Oxford University Press, Oxford: 711-726, 1992.
Wald NJ and Cuckle HS. Biochemical Screening In: Prenatal Diagnosis and Screening Ed Brock D, Rodeck C and Ferguson-Smith MA. Churchill Livingstone:563-577, London.
Wald NJ, Cuckle HS, Densem JW, Kennard A, Smith D. Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight. British Journal of Obstetrics and Gynaecology 1992;99:144-9.
Wald NJ, Cuckle HS, Densem JW, Stone RB. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome. British Journal of Obstetrics and Gynaecology 1992;99:51-3.
Wald NJ, Cuckle HS. The complementary use of biochemical serum tests and ultrasound in the detection of neural tube defects and Down syndrome: Part I Screening. In: Textbook of Ultrasound in Obstetrics and Gynaecology. Ed: Chervenak FA, Isaacson G, Campbell S. Boston: Little Brown & Co, 1992.
Wald N, Densem J, Kennard A. Antenatal screening for Down's syndrome. (Letter on age distribution and performance of screening). British Medical Journal 1992;305:1017-8.
Wald NJ, Kennard A. Prenatal biochemical screening for Down's syndrome and neural tube defects. Current Opinion in Obstetrics and Gynaecology 1992;4:302-7.
Wald NJ, Kennard A. Prenatal serum screening for Down's syndrome. American Association for Clinical Chemistry In Service Training 1992; 10(14):7-20.
Wald NJ, Kennard A, Densem JW, Cuckle HS, Chard T, Butler L. Antenatal maternal serum screening for Down's syndrome: Results of a demonstration project. British Medical Journal 1992;305:391-4.
Wald NJ, Kennard A, Densem JW, Chard T, Butler L. Antenatal screening for Down's syndrome. Reply to letters on Demonstration Project Paper. British Medical Journal 1992;305:771.
Wald NJ, Law M. Screening, ethics, and the law. (Letter in reply to Edwards and Hall). British Medical Journal 1992;305:892.
Wald N, Stone R, Cuckle HS, Grudzinskas JG, Barkai G, Brambati B, et al. First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome. British Medical Journal 1992;305:28.
Wald N, Voller A. Pregnancy associated plasma protein A in Down's syndrome. (Reply to Chard and Macintosh). British Medical Journal 1992;305:425.
Wald N, Wald K, Smith D. The extent of Down's syndrome screening in Britain in 1991. Lancet 1992;340:494.
Wathen NC, Cass PL, Campbell DJ, Wald N, Chard T. Alpha-fetoprotein levels and yolk sac size in the first trimester of pregnancy. Prenatal Diagnosis 1992;12:649-52.

The 1991-1993 publications lists were reconstructed from scanned and OCR'd material and may, despite checking, still contain errors. Please report any that you see to the Wolfson Web Manager: your help will be much appreciated.

 
Top
 

Useful links:
  WIPM publications hub
    EPM
    CCP
    Psychiatry
    GPRF/EMCU

by Wolfson Institute Website Manager © Queen Mary, University of London 2011
Centre for Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, Barts and The London, Charterhouse Square, London EC1M 6BQ Tel: 020 7882 3850 Fax: 020 7882 6270